| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,990 |
25,539 |
$3.39M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,336 |
15,713 |
$1.80M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,760 |
2,548 |
$1.69M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
13,453 |
3,072 |
$1.54M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,310 |
2,473 |
$1.16M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,541 |
3,107 |
$844K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,079 |
4,795 |
$671K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,721 |
3,126 |
$420K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,236 |
3,336 |
$268K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,376 |
1,225 |
$248K |
| 80053 |
Comprehensive metabolic panel |
17,027 |
13,393 |
$240K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,386 |
1,295 |
$217K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,611 |
1,426 |
$200K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,139 |
6,113 |
$117K |
| 87070 |
|
7,333 |
6,897 |
$95K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,178 |
1,002 |
$93K |
| 97163 |
|
609 |
555 |
$88K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,114 |
1,011 |
$82K |
| A9270 |
Non-covered item or service |
9,628 |
1,727 |
$74K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
493 |
459 |
$71K |
| 36415 |
Collection of venous blood by venipuncture |
3,178 |
2,248 |
$70K |
| 85027 |
|
26,504 |
19,376 |
$66K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,056 |
802 |
$59K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,531 |
3,992 |
$57K |
| 73610 |
|
689 |
616 |
$56K |
| G0378 |
Hospital observation service, per hour |
3,206 |
1,602 |
$52K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
119 |
111 |
$48K |
| 81001 |
|
9,814 |
8,379 |
$47K |
| 84484 |
|
8,086 |
5,390 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
11,968 |
10,138 |
$44K |
| 81025 |
|
6,535 |
5,836 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
2,511 |
2,171 |
$40K |
| 73030 |
|
771 |
649 |
$38K |
| J3490 |
Unclassified drugs |
563 |
453 |
$36K |
| 73564 |
|
872 |
777 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,844 |
2,561 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
279 |
265 |
$31K |
| 87040 |
|
4,195 |
3,042 |
$30K |
| 81003 |
|
4,266 |
3,744 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,210 |
10,319 |
$28K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,764 |
1,357 |
$27K |
| 80076 |
|
2,952 |
2,717 |
$23K |
| 87275 |
|
9,601 |
9,074 |
$22K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,721 |
7,774 |
$22K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,298 |
984 |
$22K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,224 |
1,358 |
$21K |
| 73130 |
|
629 |
576 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,494 |
7,073 |
$20K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
922 |
698 |
$20K |
| 73110 |
|
540 |
453 |
$19K |
| 92523 |
|
111 |
111 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,303 |
1,996 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
840 |
780 |
$19K |
| 73630 |
|
728 |
671 |
$19K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
192 |
159 |
$17K |
| 87088 |
|
2,458 |
1,922 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
258 |
246 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,044 |
5,510 |
$15K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
660 |
611 |
$14K |
| 85610 |
|
9,276 |
5,651 |
$12K |
| 80047 |
|
1,057 |
916 |
$12K |
| 74018 |
|
621 |
572 |
$12K |
| 83735 |
|
7,891 |
5,322 |
$11K |
| 85730 |
|
5,979 |
4,806 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,507 |
2,439 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,089 |
4,974 |
$9K |
| 74019 |
|
254 |
229 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
61 |
52 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,583 |
4,509 |
$9K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,385 |
1,142 |
$9K |
| 76830 |
Ultrasound, transvaginal |
163 |
154 |
$9K |
| 73502 |
|
215 |
172 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
329 |
257 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,351 |
7,018 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
53 |
44 |
$7K |
| 82565 |
|
99 |
72 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
585 |
472 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,177 |
4,574 |
$6K |
| 84702 |
|
686 |
571 |
$6K |
| 97162 |
|
32 |
30 |
$5K |
| 85014 |
|
18 |
14 |
$5K |
| 83605 |
|
3,308 |
2,692 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
30 |
29 |
$5K |
| 93971 |
|
62 |
54 |
$4K |
| 83690 |
|
6,919 |
5,867 |
$4K |
| 72131 |
|
74 |
70 |
$4K |
| 72110 |
|
79 |
70 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
850 |
729 |
$4K |
| 87807 |
|
3,263 |
3,113 |
$4K |
| 83880 |
|
2,268 |
1,757 |
$3K |
| 82248 |
|
1,700 |
1,184 |
$3K |
| 71250 |
|
59 |
52 |
$3K |
| 87276 |
|
9,597 |
9,073 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,146 |
1,509 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,093 |
2,227 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
618 |
560 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,343 |
897 |
$3K |
| 76536 |
|
28 |
24 |
$3K |
| 82805 |
|
314 |
231 |
$2K |
| 97167 |
|
27 |
26 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
519 |
304 |
$2K |
| 86900 |
|
618 |
522 |
$2K |
| 76641 |
|
16 |
13 |
$1K |
| 85379 |
|
1,534 |
1,273 |
$1K |
| 73620 |
|
12 |
12 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,750 |
1,303 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
754 |
614 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
129 |
102 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
927 |
801 |
$1K |
| 80061 |
Lipid panel |
1,390 |
1,015 |
$1K |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
104 |
76 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
811 |
711 |
$936.55 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,157 |
855 |
$869.48 |
| 82247 |
|
318 |
268 |
$863.03 |
| 82040 |
|
317 |
268 |
$840.17 |
| 84075 |
|
297 |
252 |
$837.62 |
| 84450 |
|
297 |
252 |
$837.62 |
| 84460 |
|
296 |
251 |
$837.62 |
| 84155 |
|
296 |
252 |
$831.75 |
| 86901 |
|
617 |
521 |
$670.82 |
| J1815 |
Injection, insulin, per 5 units |
646 |
320 |
$659.26 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
12 |
$649.34 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
17 |
17 |
$644.38 |
| 82607 |
|
514 |
346 |
$642.10 |
| 73562 |
|
44 |
39 |
$495.43 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
38 |
13 |
$429.81 |
| 88342 |
|
14 |
12 |
$403.02 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
471 |
403 |
$401.59 |
| 82150 |
|
129 |
116 |
$396.99 |
| 82077 |
|
395 |
321 |
$373.11 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
334 |
304 |
$329.95 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
22 |
12 |
$324.86 |
| 85651 |
|
497 |
427 |
$301.19 |
| 84520 |
|
50 |
44 |
$249.69 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
487 |
330 |
$232.46 |
| 86140 |
|
331 |
215 |
$230.44 |
| J2060 |
Injection, lorazepam, 2 mg |
266 |
201 |
$228.47 |
| 85018 |
|
18 |
14 |
$214.47 |
| 36600 |
|
295 |
228 |
$208.14 |
| 84703 |
|
64 |
55 |
$208.00 |
| 82550 |
|
652 |
526 |
$204.88 |
| 96376 |
|
210 |
180 |
$202.57 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
21 |
18 |
$192.29 |
| 84439 |
|
263 |
184 |
$142.10 |
| 76801 |
|
16 |
14 |
$126.70 |
| 82728 |
|
137 |
69 |
$125.76 |
| 86850 |
|
62 |
50 |
$13.02 |
| 80320 |
|
207 |
185 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
27 |
15 |
$0.00 |
| 84436 |
|
14 |
13 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
54 |
52 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
55 |
46 |
$0.00 |
| 84134 |
|
14 |
12 |
$0.00 |
| 82553 |
|
18 |
15 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,022 |
971 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
222 |
198 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
57 |
27 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
45 |
43 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
12 |
12 |
$0.00 |
| 84100 |
|
21 |
13 |
$0.00 |
| 87186 |
|
12 |
12 |
$0.00 |